Dr. Reiersen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4444 Forest Park Ave
Ste 2600
Saint Louis, MO 63108Phone+1 314-286-1700Fax+1 314-286-1777
Summary
- Angela Reiersen, MD, is a Psychiatry specialist based in Saint Louis, MO, with a subspecialty in Child & Adolescent Psychiatry. She completed her medical education at the Keck School of Medicine of the University of Southern California in 1999, followed by a Psychiatry residency and Child and Adolescent Psychiatry fellowship at Washington University/B-JH/SLCH Consortium. Her clinical experience encompasses attention deficit disorder with hyperactivity, autistic disorder, comorbidity, diseases in twins, and psychomotor disorders. Dr. Reiersen has published numerous articles in well-regarded journals, with topics ranging from the modulation of pro-inflammatory stimulation on hippocampal plasticity to the potential repurposing of fluvoxamine for COVID-19 management.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Child and Adolescent Psychiatry, 2002 - 2004
- Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 1999 - 2002
- Keck School of Medicine of the University of Southern CaliforniaClass of 1999
Certifications & Licensure
- MO State Medical License 2004 - 2025
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Publications & Presentations
PubMed
- 28 citationsFluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence.Shelley N. Facente, Angela M. Reiersen, Eric J. Lenze, David R. Boulware, Jeffrey D. Klausner
Drugs. 2021-12-01 - 230 citationsAutistic traits in a population-based ADHD twin sample.Angela M. Reiersen, John N. Constantino, Heather E. Volk, Richard D. Todd
Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2007-05-01 - 253 citationsEffect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.Gilmar Reis, Eduardo Augusto dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, Lehana Thabane, Aline Cruz Milagres
The Lancet. Global Health. 2021-10-27
Authored Content
- New Evidence of Genetic Overlap Between Atypical Sensory Reactivity and Autistic Traits: Implications for Future ResearchJanuary 2018
Press Mentions
- What’s the Evidence for Fluvoxamine in COVID-19?May 20th, 2022
- Antidepressants Giving Covid the BluesApril 28th, 2022
- Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the LabApril 19th, 2022
- Join now to see all
Grant Support
- The Intersection Of Autism And ADHDNational Institute Of Mental Health2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: